Randomized Clinical Stroke Trials in 2006

Author(s): Meheroz H. Rabadi, John P. Blass

Journal Name: Current Vascular Pharmacology

Volume 6 , Issue 1 , 2008

Become EABM
Become Reviewer
Call for Editor


This article reviews randomized control trials (RCTs) published in 2006 of various medications evaluated for stroke patients. These trials were primarily efficacy studies. These included aggrenox (an antiplatelet agent), magnesium (to treat arterial spasm after an aneurysmal subarachnoid hemorrhage), NXY (a free radical trapping agent) and albumin which were both tested as a neuroprotectant, amphetamine (to aid motor recovery), fluoxetine (an anti-depressant and anxiolytic) and low molecular weight heparin (for prevention of deep vein thrombosis post-stroke).

Keywords: Randomized control trials, stroke, rehabilitation

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [61 - 66]
Pages: 6
DOI: 10.2174/157016108783331259
Price: $65

Article Metrics

PDF: 15